Latest KFF Health News Stories
Junk Food Turns Public Villain as Power Shifts in Washington
Some Trump insiders are ready to take on the food industry. It remains to be seen whether their entrée will result in any meaningful change in government oversight of “Big Food” — or in American health.
KFF Health News' 'What the Health?': Hello, Trump. Bye-Bye, Biden.
With just days to go before the official launch of a new administration, the GOP-led Congress is putting together plans on how to enact incoming President Donald Trump’s agenda, with a particular emphasis on cutting spending on the Medicaid program. Meanwhile, the Biden administration makes major moves in its last days, including banning a controversial food dye and ordering cigarette companies to minimize their nicotine content. Joanne Kenen of Johns Hopkins University and Politico Magazine, Anna Edney of Bloomberg News, and Sandhya Raman of CQ Roll Call join KFF Health News’ Julie Rovner to discuss these stories and more. Also this week, Rovner interviews Harris Meyer, who reported and wrote the latest KFF Health News “Bill of the Month” feature, about a colonoscopy that came with a much larger price tag than estimated.
How America Lost Control of the Bird Flu, Setting the Stage for Another Pandemic
Exclusive reporting reveals how the United States lost track of a virus that could cause the next pandemic. Problems like the sluggish pace of federal action, deference to industry, and neglect for the safety of low-wage workers put the country at risk of another health emergency.
Cómo Estados Unidos perdió el control de la gripe aviar, abriendo las puertas a otra pandemia
Casi un año después del primer brote de gripe aviar en el ganado, el virus no muestra señales de detenerse. El gobierno estadounidense no consiguió eliminar el virus de los tambos cuando estaba confinado a un puñado de estados.
Trump’s Picks for Top Health Jobs Not Just Team of Rivals but ‘Team of Opponents’
The president-elect’s choices to lead the Department of Health and Human Services, as well as agencies such as the National Institutes of Health, FDA, and CDC, hold positions on issues including abortion and vaccination that are often at odds.
KFF Health News' 'What the Health?': A Colorful Cast Could Lead Key Health Agencies
President-elect Donald Trump has made his choices to fill some top jobs at the Department of Health and Human Services. They include controversial figures who were vocal critics of the Biden administration’s handling of the covid pandemic and have proposed sweeping changes to the agencies they would lead. Meanwhile, the Supreme Court heard its first two health-related cases of the term, challenging a Tennessee law barring transgender medical care for minors and, separately, challenging the FDA’s handling of e-cigarettes. Joanne Kenen of the Johns Hopkins University and Politico, Shefali Luthra of The 19th, and Sarah Karlin-Smith of the Pink Sheet join KFF Health News’ Julie Rovner to discuss these stories and more. Also this week, Rovner interviews KFF Health News’ Bram Sable-Smith, who reported and wrote the latest KFF Health News-Washington Post Well+Being “Bill of the Month” feature, about an emergency room bill for a visit that didn’t get past the waiting room.
Make America Healthy Again: An Unconventional Movement That May Have Found Its Moment
Nonmainstream doctors and leaders in health business are wielding serious muscle in shaping the incoming Trump administration’s health policies and challenging prevailing thinking on public health, disease prevention, and chronic illness.
Qué es el movimiento para “Hacer a América saludable de nuevo” (MAHA)
El regreso de Trump a la Casa Blanca ha dado un nuevo impulso a “Hacer América saludable de nuevo”, un movimiento controversial que desafía las ideas predominantes sobre la salud pública y las enfermedades crónicas.
Florida Gov. DeSantis’ Canadian Drug Import Plan Goes Nowhere After FDA Approval
Florida sued the FDA over what it said was a “reckless delay” in approving its drug importation plan. Now, nearly a year after the FDA gave the state the green light, the program has yet to begin.
El plan del gobernador de Florida para importar medicamentos más baratos de Canadá sigue en la nada
Florida solicitó crear un programa de importación en noviembre de 2020, pocos meses después que la administración Trump concediera esta opción a los estados.
What To Know About RFK Jr.’s Stances on Key Health Issues and What He Could Do at HHS
Robert F. Kennedy Jr., President-elect Donald Trump’s pick to lead the Department of Health and Human Services, is coming into the nomination process in an unusual position, with a long list of his own policy priorities separate from the president-elect’s, and a public promise by Trump to let him “go wild” on his ideas. Céline […]
Scientists Fear What’s Next for Public Health if RFK Jr. Is Allowed To ‘Go Wild’
As federal health scientists await a potential takeover by RFK Jr. and other medical skeptics in the second Trump administration, some are preparing résumés or retirement papers.
Qué le depara a la salud pública si se confirma Robert F. Kennedy Jr. como secretario de Salud
Científicos de las agencias federales de salud esperan la segunda administración de Donald Trump con incertidumbre y temor, preguntándose cómo el presidente electo conciliará filosofías radicalmente diferentes entre los líderes de su equipo.
No Evidence Trump’s Drug Program for Terminal Patients Saved ‘Thousands’ of Lives
Though the former president has repeatedly hyped the impact of his experimental drug program, there’s no basis for his claims in government data, and medical experts say he’s exaggerating.
What’s at Stake: A Pivotal Election for Six Big Health Issues
Health care has ebbed and surged as an election issue throughout the presidential campaign. Here are the ways some of the most consequential changes in health policies could hinge on whether Vice President Kamala Harris or former President Donald Trump wins.
KFF Health News' 'What the Health?': Less Than Two Weeks To Go
With Election Day rapidly approaching, abortion is gaining traction as a voting issue, according to public opinion polls. Meanwhile, states with abortion bans are reviving the lawsuit — dismissed by the Supreme Court on a technicality this year — that could roll back the availability of the abortion pill mifepristone. Sarah Karlin-Smith of the Pink Sheet, Rachel Cohrs Zhang of Stat, and Victoria Knight of Axios join KFF Health News’ Julie Rovner to discuss these stories and more. Also this week, Rovner interviews Tricia Neuman, senior vice president of KFF and executive director of its Program on Medicare Policy, about Medicare open enrollment and the changes to the federal program for 2025.
Poppy Seed Brew Triggers Morphine Overdose, Drawing Attention of Lawmakers
Poppy seeds contaminated with opioids can be used to make a deadly brew, a watchdog says.
FDA’s Promised Guidance on Pulse Oximeters Unlikely To End Decades of Racial Bias
For decades, the pulse oximeters used in hospitals, ambulances, and homes have underestimated the oxygen needs of darker-skinned patients. The FDA is preparing guidelines to fix that. But will the new rules go far enough?
Por qué se habla de discriminación racial al tomar el nivel de oxígeno
Fiscales estatales y senadores de EE.UU. han presionado a la Administración de Drogas y Alimentos para que tome medidas que ayuden a eliminar la desviación racial en los oxímetros de pulso.
Setting the Record Straight on the FDA’s Authority Over Drug Ads
KFF Health News gives readers a chance to comment on a recent batch of stories.
